Since President Biden’s Executive Order in 2021 setting priorities for enforcing antitrust law, the Federal Trade Commission and Department of Justice Antitrust Division have taken bold action to transform the landscape of health care compliance.
The No Surprises Act, which went into effect January 1, 2022, was designed to protect patients from surprise medical bills when they are treated in out-of-network emergency departments or by out-of-network providers at in-network facilities.
Cost growth benchmarking programs allow states to see a complete picture of total health care spending in their markets, and pinpoint cost drivers.
By March of this year, more than 61% of Americans had experienced a telehealth visit—and almost 88% want to continue using telehealth for nonurgent consultations, even after the pandemic passes, according to findings reported in Healthcare Finance.
Drivers of Health (DOH)—the conditions under which people live, learn, work, play and age—are proven to have a greater impact on health than medical care.
Manatt webinar take a fresh look at the 10 imperatives for advancing health through the lens of what we’ve learned through COVID-19.
We are just one quarter into 2022 and the Food and Drug Administration already has experienced a number of significant changes and developments.
Health care is facing a tidal wave of change—from enforcement actions around CARES Act funding to employment issues in a post-COVID workplace to questions around telehealth coverage to controversies over gender identity discrimination.
The federal No Surprises Act, which went into effect January 1, 2022, protects patients from surprise medical bills for emergency services and for when they are treated by out-of-network providers in an in-network facility in certain circumstances.
Big technology companies may be making headlines for antitrust scrutiny, but the Federal Trade Commission already devotes a substantial share of its resources to antitrust enforcement in health care.